Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by ANALIAS00on Feb 24, 2021 10:07am
66 Views
Post# 32645953

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:SEC filing

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:SEC filing So you are saying we should forget and forgive all bad decisions because their PR are full of "should, may, we beleive, potential,..." ? I for sure do not think so.
realitycheck4u wrote: Here's why.

“We believe (they were wrong) that being listed on NASDAQ will help (not "for sure", just help) to foster interest (not deliver it for sure, just "forster it") from more potential (not fure sure, just potential) investors and financial analysts, and that it should (not for sure) result in increased liquidity for investors.

If you cannot read a statement without also reading what it means, that's a problem my friend.

palinc2000 wrote: Lol!!!


realitycheck4u wrote: You are losing my respect. That's the stupidest comment on this board in a very long time.

palinc2000 wrote: From the August 12 2019 PR re application for Nasdaq  Listing......I am not 100% certain but I  think part of Dubuc s bonus was based on Listing on the Naz.......IF this is the case then maybe .there should be clawback clauses on bonuses 


“We believe that being listed on NASDAQ will help to foster interest from more potential investors and financial analysts, and that it should result in increased liquidity for investors. Theratechnologies will enter NASDAQ with a strong commercial portfolio and a research pipeline that will undoubtedly attract more attention and be better recognized,” said Philippe Dubuc, Senior Vice-President and Chief Financial Officer, Theratechnologies Inc


 

 






<< Previous
Bullboard Posts
Next >>